tiprankstipranks
Trending News
More News >
bioMerieux (FR:BIM)
:BIM
France Market

bioMerieux (BIM) Financial Statements

Compare
11 Followers

bioMerieux Financial Overview

bioMerieux's market cap is currently €12.54B. The company's EPS TTM is €1.35; its P/E ratio is 33.16; and it has a dividend yield of 0.82%. bioMerieux is scheduled to report earnings on September 4, 2025, and the estimated EPS forecast is €2.06. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue€ 3.98B€ 3.67B€ 3.59B€ 3.38B€ 3.12B
Gross Profit€ 2.22B€ 2.06B€ 1.96B€ 1.97B€ 1.74B
Operating Income€ 588.80M€ 439.10M€ 559.80M€ 768.00M€ 551.20M
EBITDA€ 897.50M€ 701.30M€ 811.90M€ 977.80M€ 747.70M
Net Income€ 432.20M€ 357.60M€ 452.40M€ 601.10M€ 404.40M
Balance Sheet
Cash & Short-Term Investments€ 449.80M€ 352.40M€ 552.60M€ 803.50M€ 389.20M
Total Assets€ 5.77B€ 5.26B€ 5.19B€ 4.61B€ 3.93B
Total Debt€ 490.70M€ 518.80M€ 505.40M€ 462.50M€ 481.30M
Net Debt€ 40.90M€ 166.40M€ -47.20M€ -341.00M€ 92.10M
Total Liabilities€ 1.56B€ 1.51B€ 1.54B€ 1.44B€ 1.45B
Stockholders' Equity€ 4.20B€ 3.75B€ 3.60B€ 3.11B€ 2.43B
Cash Flow
Free Cash Flow€ 321.50M€ 107.10M€ 188.40M€ 534.60M€ 305.30M
Operating Cash Flow€ 667.30M€ 445.40M€ 475.10M€ 824.70M€ 582.80M
Investing Cash Flow€ -359.80M€ -488.80M€ -528.10M€ -307.30M€ -266.00M
Financing Cash Flow€ -212.60M€ -122.30M€ -244.20M€ -140.60M€ -175.40M
Currency in EUR

bioMerieux Earnings and Revenue History

bioMerieux Debt to Assets

bioMerieux Cash Flow

bioMerieux Forecast EPS vs Actual EPS